BRAINSTORM CELL THERAPEUTICS INC.·4

Aug 3, 9:20 PM ET

Harel Adrian 4

4 · BRAINSTORM CELL THERAPEUTICS INC. · Filed Aug 3, 2012

Insider Transaction Report

Form 4
Period: 2012-08-01
Harel Adrian
Acting Chief Executive Officer
Transactions
  • Award

    Stock Option (right to buy)

    2012-08-01+70,00070,000 total
    Exercise: $0.26From: 2013-08-01Exp: 2022-08-01Common Stock (70,000 underlying)
Footnotes (1)
  • [F1]Option vests as to 33 1/3% of the number of shares on the first anniversary of the grant date and then monthly thereafter until fully vested on the third anniversary of the grant date.

Documents

1 file
  • 4
    v320417_4.xmlPrimary

    OWNERSHIP DOCUMENT